MYC and lymphoma: Although all were elevated in the Eμ-Myc/cRel−/− lymphomas, the comparatively smaller increase (1.7 c.f. 8.8 fold change) in the relative abundance of the fully tryptic phosphopeptide suggests additional localised structural differences that change trypsin accessibility and thus the ability to generate the ‘limit’ peptide.